Neuralink has secured $600M in funding, raising its valuation to $9B. The funding will support the development and clinical testing of its brain-computer interface implants, which have received FDA "breakthrough" designation for treating conditions like spinal cord injuries.
- Company
- Neuralink
- Amount
- $600M
- Source
- trial.medpath.com
- In the newsletter
- No. 173, What Actually Makes Money in Nvidia’s AI Servers